Greenwich LifeSciences (GLSI)’ GLSI-100 Cuts Breast Cancer Recurrence by 80% in Trials
Greenwich LifeSciences Inc. (NASDAQ:GLSI) is a clinical-stage biopharmaceutical company dedicated to developing novel immunotherapies designed to prevent breast…